Skip to main content
Clinical Trials/NCT07457372
NCT07457372WithdrawnNot Applicable

How Does Vagus Nerve Stimulation Affect Blood Glucose, Food, and Movement Cravings?

University of Minnesota1 site in 1 country8 target enrollmentStarted: September 1, 2026Last updated:
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Enrollment
8
Locations
1
Primary Endpoint
Change in plasma glucose

Study Overview

Brief Summary

The purpose of this study is to determine the feasibility of using non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) to examine physiological and psychological responses in a college-aged healthy population

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Basic Science
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to 35 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Participants must be between the ages of 18 and 35 as we are focused on recruiting undergraduate and graduate students.

Exclusion Criteria

  • Participants will be excluded if they have epilepsy, clinically significant tachycardia or arrhythmia, diabetes (Type 1 or Type 2) or another metabolic disease, current pregnancy, any implanted electronic medical device (for example, pacemaker or defibrillator), or a known skin allergy to adhesives that would prevent CGM placement. Participants will also be excluded if they have a history of major depressive disorder if taVNS could reasonably be expected to alter mood symptoms

Arms & Interventions

Active taVNS

Active Comparator

Intervention: Active taVNS (Device)

Sham taVNS

Placebo Comparator

Intervention: Sham taVNS (Device)

Outcomes

Primary Outcomes

Change in plasma glucose

Time Frame: Hour 2 after oral glucose load

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials